Atossa Therapeutics (ATOS) - Shares outstanding

Number of shares outstanding as of May 2026 : 8,611,428

According to Atossa Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 8,611,428. At the end of 2025 the company had 8,611,428 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Atossa Therapeutics from 2018 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	8.61 M	2.7%
2024	8.38 M	-0.02%
2023	8.38 M	-0.66%
2022	8.44 M	0.07%
2021	8.43 M	1145.11%
2020	0.67 M	11.31%
2019	0.6 M	76.14%
2018	0.34 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,408,700,000	27,870.97%	🇺🇸 USA
Quest Diagnostics DGX	110,000,000	1,177.37%	🇺🇸 USA
LabCorp LH	82,300,000	855.71%	🇺🇸 USA
Translate Bio TBIO.defunct	62,908,800	630.53%	🇺🇸 USA
NeoGenomics NEO	129,166,000	1,399.94%	🇺🇸 USA
Enzo Biochem ENZB	52,403,000	508.53%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Atossa Therapeutics (ATOS)

Number of shares outstanding as of May 2026 : 8,611,428